Is Vision Therapy a Hoax? What the Evidence Actually Shows
Medically reviewed by Dr. Puneet, B.Optom, BNYS, Medical Director, Cure For Eyes, Gurugram.
It is a fair question, and it gets asked often enough that it turns up in Google’s autocomplete.
The honest answer is that vision therapy is neither a hoax nor a cure-all. Some of it is backed by large randomised trials funded by the United States National Eye Institute. Some of it is not supported by good evidence at all. The problem is that both get sold under the same name.
Here is where the line falls.
What the strongest evidence supports
The best-studied use of vision therapy is convergence insufficiency, a condition where the eyes struggle to turn inward together for near work. It causes eyestrain, headaches, losing your place while reading, and sometimes double vision.
The Convergence Insufficiency Treatment Trial was a randomised clinical trial funded by the National Eye Institute. It enrolled 221 children aged 9 to 17 and compared four approaches: home-based pencil push-ups, home-based computer therapy with pencil push-ups, office-based therapy with home reinforcement, and a placebo therapy designed to look and feel like real treatment.
After 12 weeks, about 75 per cent of the children receiving office-based vision therapy with home reinforcement had achieved normal vision or significantly fewer symptoms. Home-based therapy alone reached about 43 per cent, and pencil push-ups alone about 33 per cent.
That last detail is what separates this from anecdote. Office-based vergence and accommodative therapy was the only treatment studied that beat placebo. A placebo-controlled trial is precisely the test a hoax fails.
A later trial, CITT-ART, enrolled 310 children aged 9 to 14 and replicated the core finding: 75 to 80 per cent of children in the vision therapy group improved into the normal range on clinical signs, against roughly 30 per cent on placebo.
So for convergence insufficiency, the answer is settled. It works, and it has been shown to work against placebo, more than once, in trials that were properly powered and independently funded.
What the evidence does not support
This is the part most clinic websites leave out.
The American Academy of Pediatrics, the American Academy of Ophthalmology, the American Association for Pediatric Ophthalmology and Strabismus, and the American Association of Certified Orthoptists issued a joint statement on learning disabilities, dyslexia and vision. Their position is that scientific evidence does not support eye exercises, behavioural vision therapy, or tinted filters and lenses for improving long-term educational performance in these conditions, and that such approaches should not be recommended for that purpose.
Dyslexia is understood by most experts to be a language-based disorder. It is not caused by an eye problem, and treating the eyes does not treat it.
The CITT-ART trial mentioned above tested this directly. It was designed to find out whether successfully treating convergence insufficiency would improve children’s reading scores. It did not. The vision therapy group improved on the eye measures and did not improve on reading tests compared with placebo.
Read those two results together, because that is the whole argument in one place. The same research programme that proved vision therapy works for convergence insufficiency also proved it does not fix reading ability. Both findings are true. A clinic that quotes only the first is selling you something.
Where the reasonable disagreement sits
Between “proven” and “disproven” is a genuine grey area, and it is worth being straight about it.
The optometric position is that vision therapy does not treat dyslexia directly, but that a child can have both a language-based reading disorder and a separate visual efficiency problem. Treating the visual problem does not cure the dyslexia. It may remove one barrier that was making reading uncomfortable or tiring.
That is a more modest claim than the marketing usually makes, and it is a defensible one. What it does not justify is offering vision therapy as a treatment for a learning disability, or implying that reading scores will rise.
How to tell a legitimate provider from a poor one
A legitimate provider diagnoses before treating. You should receive an actual binocular vision assessment, with measurements: near point of convergence, fusional vergence ranges, accommodative amplitude and facility, eye alignment, and a symptom survey. If someone recommends a programme without measuring these, walk away.
They name the condition being treated. “Convergence insufficiency” is a diagnosis. “Your eyes need training” is not.
They tell you what it will not do. If a clinic tells you vision therapy will improve your child’s marks, concentration, dyslexia or ADHD, the published evidence does not support that.
They set a review point. Reassessment after a defined number of weeks, with the same measurements repeated, so progress is a number and not a feeling.
They do not sell open-ended packages. Convergence insufficiency trials ran 12 weeks. A programme with no endpoint is a business model, not a treatment plan.
So, is it a hoax?
No. For convergence insufficiency it is one of the better-evidenced treatments in eye care, having beaten placebo in more than one properly designed trial. For amblyopia and certain binocular vision problems there is a real and growing evidence base.
For dyslexia, learning disabilities and academic performance, the major paediatric and ophthalmology bodies say the evidence is not there, and we agree with them.
The scepticism you have encountered is not unreasonable. It is a response to overclaiming by parts of this field. The answer is not to overclaim in the other direction.
At Cure For Eyes in Gurugram we assess and treat binocular vision conditions, and our vision therapy programme is built on diagnoses with measurable endpoints. If a proper assessment shows vision therapy is not what you need, we will tell you that. Book an assessment if you want a straight answer about your own eyes.
Frequently asked questions
Is vision therapy scientifically proven?
For convergence insufficiency, yes. Office-based vergence and accommodative therapy was the only treatment in the National Eye Institute funded Convergence Insufficiency Treatment Trial that outperformed placebo, with around 75 per cent of children improving. For learning disabilities and dyslexia, the major paediatric and ophthalmology bodies state the evidence does not support it.
Does vision therapy help with dyslexia?
No. A joint statement by the American Academy of Pediatrics, the American Academy of Ophthalmology and others concludes that scientific evidence does not support eye exercises or behavioural vision therapy for improving long-term educational performance. The CITT-ART trial tested this and found no improvement in reading scores over placebo.
Is vision therapy better than eye exercises at home?
For convergence insufficiency the trial data says yes. Office-based therapy with home reinforcement reached about 75 per cent success against about 43 per cent for home-based therapy alone and about 33 per cent for pencil push-ups alone.
How long should vision therapy take?
The major trials ran 12 to 16 weeks. Be cautious about programmes with no defined endpoint or review date.
Why do some ophthalmologists say vision therapy does not work?
Much of that scepticism is aimed at claims that vision therapy treats dyslexia, ADHD or learning disabilities, where they are right that the evidence is lacking. It is not generally aimed at treatment of convergence insufficiency, where the trial evidence is strong.
Dr. Puneet, B.Optom, BNYS, Medical Director, Cure For Eyes, Gurugram.
This article is for general information and is not a substitute for a clinical examination.
One Response